ZA966775B - Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections. - Google Patents

Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections.

Info

Publication number
ZA966775B
ZA966775B ZA9606775A ZA966775A ZA966775B ZA 966775 B ZA966775 B ZA 966775B ZA 9606775 A ZA9606775 A ZA 9606775A ZA 966775 A ZA966775 A ZA 966775A ZA 966775 B ZA966775 B ZA 966775B
Authority
ZA
South Africa
Prior art keywords
pct
combination
antibiotics
treatment
bacterial infections
Prior art date
Application number
ZA9606775A
Other languages
English (en)
Inventor
Peter Scholz
Joerg Weber
Klemens Angstwurm
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA966775B publication Critical patent/ZA966775B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9606775A 1995-08-11 1996-08-08 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections. ZA966775B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19530884A DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis

Publications (1)

Publication Number Publication Date
ZA966775B true ZA966775B (en) 1997-02-19

Family

ID=7770106

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606775A ZA966775B (en) 1995-08-11 1996-08-08 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections.

Country Status (25)

Country Link
US (1) US6040336A (no)
EP (1) EP0852497B1 (no)
JP (1) JPH11510809A (no)
CN (1) CN1080562C (no)
AT (1) ATE219368T1 (no)
AU (1) AU702706B2 (no)
BR (1) BR9609932A (no)
CA (1) CA2228036A1 (no)
CZ (1) CZ291534B6 (no)
DE (2) DE19530884C2 (no)
DK (1) DK0852497T3 (no)
ES (1) ES2181907T3 (no)
HK (1) HK1015707A1 (no)
HU (1) HUP9802450A3 (no)
IL (1) IL122826A (no)
MX (1) MX9801118A (no)
NO (1) NO316424B1 (no)
PL (1) PL184840B1 (no)
PT (1) PT852497E (no)
RU (1) RU2201232C2 (no)
SK (1) SK284195B6 (no)
TR (1) TR199800128T1 (no)
UA (1) UA54397C2 (no)
WO (1) WO1997006806A1 (no)
ZA (1) ZA966775B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663967B1 (en) * 2000-11-17 2003-12-16 Bryant Rubber Corporation Moldable silicone elastomers having selective primerless adhesion
WO2008058766A1 (en) * 2006-11-16 2008-05-22 Bayer Schering Pharma Aktiengesellschaft Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection
EP2803365A1 (en) 2013-05-14 2014-11-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis
CA3167058A1 (en) 2020-02-12 2021-08-19 Cytoagents, Inc. Compositions and methods for treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447802A (en) * 1891-03-10 Irvest williams
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4665088A (en) * 1984-11-14 1987-05-12 The Research Foundation Of State University Of New York (E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides
FI870658A (fi) * 1986-02-18 1987-08-19 Syntex Inc Infektionshindrande injicerbara produkter.
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
AU699085B2 (en) * 1994-04-21 1998-11-19 Schering Aktiengesellschaft PDE IV inhibitors for treating Multiple Sclerosis

Also Published As

Publication number Publication date
AU702706B2 (en) 1999-03-04
NO980568L (no) 1998-02-10
NO316424B1 (no) 2004-01-26
EP0852497B1 (en) 2002-06-19
DK0852497T3 (da) 2002-08-12
US6040336A (en) 2000-03-21
JPH11510809A (ja) 1999-09-21
NO980568D0 (no) 1998-02-10
BR9609932A (pt) 1999-06-08
CN1192684A (zh) 1998-09-09
ATE219368T1 (de) 2002-07-15
IL122826A0 (en) 1998-08-16
AU6871196A (en) 1997-03-12
HK1015707A1 (en) 1999-10-22
PT852497E (pt) 2002-10-31
ES2181907T3 (es) 2003-03-01
RU2201232C2 (ru) 2003-03-27
DE19530884A1 (de) 1997-02-20
HUP9802450A2 (hu) 1999-02-01
SK284195B6 (sk) 2004-10-05
PL324884A1 (en) 1998-06-22
MX9801118A (es) 1998-10-31
EP0852497A1 (en) 1998-07-15
CN1080562C (zh) 2002-03-13
DE69621939T2 (de) 2003-01-09
DE19530884C2 (de) 1997-07-31
TR199800128T1 (xx) 1998-04-21
CZ291534B6 (cs) 2003-03-12
CZ41498A3 (cs) 1998-09-16
PL184840B1 (pl) 2002-12-31
DE69621939D1 (de) 2002-07-25
HUP9802450A3 (en) 1999-08-30
CA2228036A1 (en) 1997-02-27
UA54397C2 (uk) 2003-03-17
WO1997006806A1 (en) 1997-02-27
SK15698A3 (en) 1998-06-03
IL122826A (en) 2001-11-25

Similar Documents

Publication Publication Date Title
MX9805416A (es) Derivados de carbamoiloxi de mutilina y su uso como antibacterianos.
CA2031803A1 (en) Improvements in or relating to glycopeptide deriveratives
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
PL307914A1 (en) Lipopetide derivatives, method of obtaining them and therapeutic agents containing such compounds
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
NZ504503A (en) Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents
ATE161265T1 (de) Derivate von 16-gliedrigen antibiotischen macroliden
FI962488A0 (fi) HIV:n proteaasin inhibiittoreita
DK312688D0 (da) Glykkopeptid-antibiotika
EP0869801A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS
SI0808326T1 (en) Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
SI0801655T1 (en) Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
HK1015707A1 (en) Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections
ATE337002T1 (de) Topische behandlung zur vorbeugung von augeninfektionen
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
AP9701040A0 (en) Novel compounds.
IT1269873B (it) Nuovi derivati chinolonici, sintesi ed impiego come farmaci antibatterici